(R)-3-(Difluoromethyl)pyrrolidine hydrochloride, 98%, 500mg

2-(5-Methoxy-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 500mg

1-(4-Bromo-1H-pyrazol-1-yl)-2-methylpropan-2-ol, 97%, 1g

Tofacitinib metabolite-1, 5mg

(3aR,6R,6aR)-2,2,6-Trimethyl-6-vinyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-one, 98%, 250mg

4H,5H,6H,7H-Thieno[2,3-c]pyridine, 95+%, 1g

3-(1,3-Dioxo-1,3-dihydro-isoindol-2-yl)propionic acid, 98.0%, 100g

4-Methoxy-1-methyl-1H-indole, 97%, 100mg

2-pyrrolidin-1-yl-1,3-benzothiazol-6-ol, 95.0%, 250mg

tert-Butyl 3-(2-bromophenyl)pyrrolidine-1-carboxylate, 95.0%, 250mg

Cyclohexyl anthranilate, 98.0%, 1g

6-BROMO-2-CHLORO-1-METHYL-1H-BENZO[D]IMIDAZOLE, 95.0%, 500mg

2-(Tert-butyl)-1,3,4-oxadiazole, 98%, 250mg